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The choice of outcome (or outcomes) and their measurement are critical for a sound clinical trial. Surgeons have tra­
ditionally measured simple outcomes such as death, duration of survival, or tumor recurrence but have recently devel­
oped more sophisticated measures of the effect of an intervention. Many outcome measures require a lengthy matura­
tion process, which includes a determination of the instrument’s validity, reliability, and sensitivity; thus, using 
established instruments rather than creating new ones is recommended. The authors illustrate several guidelines for the 
determination of appropriate outcome measures by using examples from their experience and describe several outcome 
measures that can be used in pediatric neurosurgery. These include general outcome measures such as the Pediatric 
Evaluation of Disability Inventory and the Functional Independence Measure for Children, which measure physical 
function and independence in chronically ill and disabled children as well as disease-specific measures for hydro­
cephalus (Hydrocephalus Outcome Questionnaire), cerebral palsy (gross motor function and performance measures), 
head injury (Pediatric Cerebral Performance Category and Children’s Coma Scale), and oncology (Pediatric Cancer 
Quality-of-Life Inventory).
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u n ic a l  research is an integral part of current neuro- 
I  surgical practice. One of the most important com­
ponents of a clinical research project is the choice of 
the outcome and the way in which it is measured. In some 
areas of neurosurgical interest, the outcome is obvious (for 
example, survival time), but in others (for example, spas­
ticity), the development and testing of an outcome measure 
have required years of work and investigation.41' In this arti­
cle, we describe the parameters by which outcome mea­
sures are assessed and the process of developing an out­
come measure when an appropriate one is not available. To 
assist clinical investigators in pediatric neurosurgery, we 
also describe a number of outcome measures that may be 
useful to them.
Outcome Measures
An outcome measure refers to any tool used to evaluate 
the effect of a disease and/or treatment on the health status 
of a patient. Traditionally, surgeons have been interested in 
outcomes that represent pathological, physiological, or clin­
ical variables, such as death, pain, tumor growth, or bone 
fusion. As the science of outcome measurement has 
evolved, two advances have emerged First, scales have 
been developed to improve the precision of the “traditional” 
outcome measures. For example, pain can be scored in
Abbreviation used in this paper: GCS = Glasgow Coma Scale.
a reproducible way, rather than by being reported as “im­
proved” or "unchanged.” Ambulation can be graded 
(American Spinal Injury Association motor score) rather 
than being recorded as present or absent. Second, “nontra- 
ditional” outcome measures, especially those that attempt to 
capture information on other domains within the patient’s 
life, have been developed.
Depending on the study, the outcome(s) of interest may 
be related to clinical signs and symptoms, imaging find­
ings, functional abilities (physical, cognitive, social), survi­
val, quality of life, patient satisfaction, and/or cost of care. 
Often there are several outcomes of interest, but every at­
tempt should be made to identify a single primary outcome. 
This focus will allow an investigator to define a specific 
study hypothesis, calculate a sample size (which will deter­
mine budget and feasibility), and draw clear, specific con­
clusions.
Many factors should be considered when selecting a pri­
mary outcome, depending on the study question, but for 
clinical questions the following two principles should be 
kept in mind: 1) What is important to the patient? To an­
swer this, patients or patient advocacy groups should ideal­
ly be involved in the decision, because their opinions may 
not always be obvious. 2) What would make me change my 
practice? In other words, is the outcome of sufficient im­
portance to justify the risk, convenience, and cost of the 
treatment?
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Evaluating and  Designing Outcom e M easuresCZJ E J EJ
Designing, testing, and implementing outcome measures 
other than simple dichotomous variables, such as death, is 
a lengthy and complex process.20-44-50 After deciding which 
outcomes should be measured, the clinical investigators 
should review the relevant literature to find outcome mea­
sures that have already been designed and evaluated by oth­
ers. This approach saves considerable time and effort and 
can make the results of the study more comparable with 
other studies that use similar outcome measures.
When selecting an outcome measure from the literature 
(or developing a new one), three important characteristics 
should be considered: reliability, validity, and responsive­
ness. Reliability is the extent to which the same result is ob­
tained when a measure is applied more than once. Interrater 
reliability refers to the degree of agreement between differ­
ent observers at the same point in time. Intrarater reliabili­
ty measures the degree of agreement by the same observer 
at different points in time. Reliability is usually assessed 
first in the development of an outcome measure, because 
other parameters are irrelevant if the measure is not reli­
able. The validity of an outcome measure is the extent to 
which it measures what it is supposed to measure. Face 
validity is a subjective judgment about whether a measure­
ment makes sense intuitively (that is, does it appear to mea­
sure what it is intended to measure?). Content validity is a 
judgment about whether the instrument samples all of the 
relevant or important content or domains.
Demonstrating validity requires more than peer judg­
ments, however. If an accepted outcome measure already 
exists (a gold standard), then one can administer it along 
with the new one and measure the correlation between the 
two. This pairing is known by various terms such as con­
vergent, criterion, or concurrent validity. When no gold 
standard exists, one must link the measure under investiga­
tion to some other attribute by a hypothesis or construct. 
This paradigm is called construct validity (for example, if a 
new scale is being developed to measure the severity of 
subarachnoid hemorrhage, one would expect it to be corre­
lated to the patients’ Hunt and Hess grades).
Responsiveness is the ability of an instrument to measure 
a meaningful or clinically important change in a clinical 
state. Responsiveness is particularly important if a measure 
is used to follow individual patients over time. We refer 
readers to the excellent article by Cohen and Marino15 and 
other articles that apply these concepts to functional and 
other outcome measures.2-1-19-®
Health status measures can be either generic or specific.44 
Generic or global outcome measures are used to assess 
health status across disease states but may not specific 
enough to detect important changes in a particular condi­
tion. They can be viewed as health profiles and are designed 
to be applicable to a broad range of different interventions, 
diseases, and populations. Generic measures often have 
well-established reliability and validity; however, they may 
not be as responsive as disease-specific measures and may 
not focus on the more important outcomes of a particular 
disease. Conversely, disease-specific outcome measures are 
designed to concentrate attention on domains specific to a 
particular disease, population, or area of functioning.25 
Their advantages are improved responsiveness and greater 
willingness of physicians to use them in clinical studies.
Their primary disadvantage is in their inherently limited ap­
plicability.
In addition to these parameters, the following questions 
should be considered when choosing or developing an out­
come measure: 1) Is the measure acceptable to patients 
(that is, what is the burden to the patients)? For example, if 
it is a questionnaire, will they complete it or is it too long, 
complex, or boring? 2) Does it matter to patients? Is it 
something that will make a difference in their survival, 
health, or quality of life? 3) Is it feasible (that is, what is the 
administrative burden)? Can I assess this outcome in my 
practice? If the outcome is supposed to be measured after 5 
years of follow up, will I be able to track the patients for 
that long? 4) Does it matter to healthcare professionals? 
Will the results, based on this outcome measure, result in a 
change in clinical practice?
Avoiding O bserver Bias: An Exam ple From  
Hydrocephalus Research
In the Shunt Design Trial and the Endoscopic Shunt 
Insertion Trial, the outcome of interest was shunt failure, 11-12 
Initially, shunt failure was to be defined simply as the need 
for a shunt revision, but the following two potential prob­
lems were identified with this plan: 1) Different surgeons 
have different indications for reoperation. 2) The surgeons 
were not blinded to the study. This setup resulted in a po­
tential observer bias, which occurs when the person assess­
ing the outcome knows which treatment was given. This 
knowledge can influence their assessment of the outcome. 
Because of this potential observer bias, “need for reoper­
ation” would not be an appropriate definition of the prima­
ry outcome in the Shunt Design Trial and the Endoscopic 
Shunt Insertion Trial.
The literature at the time did not include a definition of 
shunt failure. It appeared that shunt failure and shunt revi­
sion surgery were synonymous. We therefore developed 
definitions by consensus among the investigators on the 
basis of history, physical findings, and ancillary tests. Sep­
arate definitions were developed for shunt obstruction, 
shunt overdrainage, loculated ventricles, and shunt infec­
tion.17 At the time of follow up, if the patient met any of the 
definitions in a blinded review of a follow-up examination, 
he or she was said to have reached the selected primary 
study end point: shunt failure.
To remove the potential observer bias, the presence or 
absence of shunt failure was blindly reviewed in all study 
patients. When a patient was seen at follow up, the clinical 
notes, data forms, and imaging studies were copied and 
sent to the data coordinating center, where they were blind­
ed (patient names, center names, and valve information 
were removed). The blinded material was then reviewed by 
two of the investigators and, when necessary to resolve dif­
ferences, by an independent committee. The blinded 
review process determined whether the patient met the def­
inition of the study end point (shunt failure) and was used 
for the primary analysis and conclusions of the study. This 
process also allowed an assessment of whether the sur­
geons’ assessments of outcome were biased. The shunt sur­
vival curves based on the blinded review were compared 
with the curves based on the surgeons’ unblinded decision 
to operate or not. For each of the three valves, the shunt sur­
vival rate based on the surgeons’ decision appeared slight­
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ly better, but the differences were not large enough to alter 
the primary study conclusions.® Although the adjudication 
process was laborious, it ensured that observer bias did not 
influence the results. This is important because observer bi­
as is always a potential threat, and its magnitude and direc­
tion are not predictable before a study.
Outcom e M easures Used in Pediatric N eurosurgery
Researchers face several methodological challenges 
when developing and applying outcome measures in pedia­
trics. 14-24-2W9-42 Any study of outcomes in pediatric patients 
must account for the physical growth from infancy through 
adolescence and the changes in behavioral, social, and psy­
chological development. An outcome measure appropriate 
for a teenager is unlikely to be appropriate for a toddler or 
baby. Thus, outcome measures should be chosen to be 
specific to each stage of child development (infancy, early 
childhood, late childhood, and adolescence). Most of the 
validated health status measurement scales in the literature 
have been developed for adults. Some have been modified 
from their adult form to be used in children, and a few have 
been developed specifically for children. In a review of the 
literature, Forrest and colleagues-* found few studies that 
examined the health effects of preventive, diagnostic, long­
term management, and curative services delivered to chil­
dren and adolescents. Although much progress has been 
made in the field of pediatric outcomes research, the unique 
challenges with pediatrics have prevented widespread use 
of these instruments.24
Exam ples of Outcome M easures
Considering the work required to develop a validated 
outcome measure from scratch, an investigator’s first step 
should be to look for an established one that might be use­
ful. Several outcome measures that are potentially useful 
in pediatric neurosurgery are outlined.
Generic Outcome M easures
S im ival. Survival is the primary outcome in most oncol­
ogy and trauma studies. For conditions in which death is 
unlikely, this measure is not sensitive enough to detect im­
portant changes, thus other clinical outcomes are more im­
portant.
Pediatric Evaluation o f  Disability Inventory. This scale 
measures physical function and independence in chronical­
ly ill and disabled children by assessing self-care mobility 
and social function. Its reliability and validity in children 
whose ages fall between 6 months and 7 years have been 
thoroughly evauated.2UW1-52
Functional Independence M easure fo r  Children. This 
scale requires a trained observer to assess the degree of as­
sistance required by disabled patients. It was originally 
developed for adults, but the reliability of a modification2'3 
has been demonstrated for use in nondisabled children 6 
months to 8 years of age and in developmental^ disabled 
children aged 6 months to 12 years. It has been applied to 
children with spina bifida.
M otor Control Assessment. This measurement requires 
a clinician to assess motor control skills. It has been vali­
dated in children between 2 and 5 years of age with mild-
to-severe physical disability and has good demonstration 
of validity and reliability.47
Short Form-36. This popular self-administered question­
naire measures physical and social function, role limita­
tions caused by physical or emotional problems, and gen­
eral health perception. Its advantage is its wide use in many 
diseases, but it is limited in pediatric use to adolescents and 
older teenagers.9
Sickness Impact Profile. This 136-item scale was de­
signed for use across many disorders to measure perceived 
health status.10 It was not designed for use in children but 
may be suitable for use with teenagers.
Rand Health Status M easure fo r  Children, This was the 
first published attempt to assess children’s health-related 
outcomes on a large scale.18 It is designed to evaluate four 
core domains, as well as general health perception and be­
havior problems, through questions to the parents. There 
are versions for children 0 to 4 years of age and those 5 to
13 years of age.
Functional Status II-R. This measure evaluates parents’ 
perceptions of the impact of their child’s (age 0-16 years) 
illness on physical, social, and psychological functions.48 
An item is scored as having an impact on functional status 
if the parent states that the problem results from the child’s 
current illness.
Child Health and Illness Profile-Adolescent Edition. This 
is the first instrument that deals specifically with health 
assessment in adolescents (11-17 years of age).52 It assess­
es comfort/discomfort, satisfaction with health, risk, dis­
order, achievement of social expectations in major role ac­
tivities, and resilience. It has been shown to be reliable 
and to have construct validity.52
Other global measures of health outcomes addressing 
children include the School Function Assessment, Child 
Health Questionnaire, Questionnaire for Identifying Chil­
dren with Chronic Conditions, Abilities Index, Youth Qual­
ity of Life Instrument-Research Version, and Quality of 
Well-Being Scale.
Disease-Specific Outcome M easures
Spasticity Assessm ent
Gross Motor Function Measure. This measure was de­
signed by a trained observer specifically for children with 
cerebral palsy and has been used in surgical studies of spas­
ticity.49 It assesses gross motor skills and specifically mea­
sures the quantity of each particular skill, not the quality.4'3
Gross M otor Performance Measure. A trained clinician 
can assess the quality of movement of patients with cere­
bral palsy in terms of alignment, coordination, dissociated 
movements, stability, and weight transfer.11 It has also un­
dergone validity and reliability testing.
Ashworth Scale. This commonly used simple scale grades 
the degree of spasticity in an extremity from 0 to 4 .4 It has 
a high level of interrater reliability.7
Epilepsy Assessm ent
Quality o f  Life in Newly D iagnosed Epilepsy Instrument. 
This quality-of-life measure was developed for use with 
recently diagnosed epilepsy patients.' It has good validity
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and reliability in adults and may be appropriate in older 
children or teens with epilepsy.
Seizure Severity and Side Effects Scales fo r  Childhood Ep­
ilepsy. These scales are completed by the parents of chil­
dren 4 to 16 years of age with chronic epilepsy as well as 
children with neurological comorbidity.'- In a group of 80 
children, the scales showed good internal consistency and 
good test-retest reliability.
Adolescent Psychosocial Seizure Inventory. This outcome 
instrument assesses the psychosocial problems of adoles­
cent patients with epilepsy analogous to the Washington 
Psychosocial Seizure Inventory used in adults.6
H ead Injury
Several outcome measures have been used in clinical tri­
als of head injury. In 1991, recommendations for outcome 
measures in traumatic brain injuries were issued. These rec­
ommendations were not made for patients younger than 16 
years of age but may be applicable to older children." For 
studies of severe brain injury (GCS Scores 3-8), the Glas­
gow Outcome Scale or the Disability Rating Scale mea­
sured 6 months after the injury were recommended as the 
primary outcome measures. In moderate brain injury (GCS 
Scores 9 - 12), the Disability Rating Scale at 3 months after 
injury was recommended as the primary outcome. In addi­
tion, the following neuropsychological tests were recom­
mended on the basis of their previous use and validity in 
brain injury research, their relevance to quality of life and 
capability of returning to work, and their brevity: Digital 
Symbol Substitution, Paced Auditory Serial Addition, Rey 
Complex Figure, Selective Reminding, Controlled Oral 
Word Association, Trail Making B, Wisconsin Card Sort­
ing, Grooved Peg Board, and Neurobehavioral Rating 
Scale.
Scales more specific to children include the following:
Pediatric Cerebral Performance Category. This easy-to- 
complete scale provides useful information regarding prob­
able outcomes of patients in the pediatric intensive care un­
it.” The scores in 200 children had good correlation with 
Stanford Binet Intelligence scores, the Bayley Scales of In­
fant Development, and the Vineland Adaptive Behavior 
Scale.
Children’s Coma Scale. In this scale, the best verbal re­
sponse portion of the GCS is modified for children.27 Pedi­
atric scores can be compared directly with those from the 
adult population. Reliability and validity data are not avail­
able. Other variations of the GCS include the Children's 
Coma Score by Raimondi, the Pediatric Coma Scale, and 
the Jacobi Comatose Management Score.
King's Outcome Scale fo r  Childhood Head Injury. Another 
pediatric (patient age range 2-16 years) adaptation of the 
original Glasgow Outcome Scale, this measure has in­
creased sensitivity at the milder end of the disability range. 
Validity and reliability testing have been reported. 16
Outcome Score According to Kriel. This scale has two 
parts: cognitive (0-4 points) and motor (0-5 points) 
scores. This score is useful in neurotrauma studies with 
extended follow-up periods.-'4
Risk Score fo r  Posttraumatic Epilepsy in Childhood. This 
score assesses the risk of development of posttraumatic
epilepsy in children based on mechanism of injury, type of 
injury, and age.-u
Outcome o f  M yelomeningocele
Spina Bifida Health-Related Quality o f  Life Instrument. Re­
liability of this instrument for patients with spina bifida was 
good, but validity was better in older children than in youn­
ger ones. Further testing of responsiveness is underway.4-*
Outcome o f  H ydrocephalus
Hydrocephalus Outcome Questionnaire. This 10- to 15- 
minute parent questionnaire measures quality of life in chil­
dren 5 years of age and older with hydrocephalus. Ex­
cellent reliability and validity have been demonstrated.-*6-*7
Imaging M easurements. Frontal and occipital horn ratio 
is a measurement of ventricular size on axial brain images 
(computerized tomography or magnetic resonance imag­
ing) that more accurately reflects ventricular volume than 
the Evans ratio does. Its interrater reliability is very good. 
It is obtained by averaging the widest distance across the 
frontal and occipital horns and then dividing it by the larg­
est biparietal diameter. Measurements can be taken from 
different slices to determine the maximum for each item in 
the equation.-*5
Pain Rating
Children ’s Global Rating Scale. This scale specifically 
for children measures their self-report of pain and fear. Its 
convergent and predictive validities have been demon­
strated in an assessment of 145 children undergoing phle­
botomy.1-*
Oncology Scales
The Pediatric Cancer Quality-of-Life Inventory. This in­
strument is not specific to neurooncology but is intended 
for use in the general population of pediatric cancer pa­
tients. Initial testing is promising, but further assessment 
of validity and reliability is required.51
Quality o f  Life Assessm ent Form— Children. This scale 
assesses the quality of life of children with cancer as re­
ported by their parents.8
Neurological Severity Score.5 This score assesses the 
neuropsychological and intellectual outcomes based on 
preoperative, perioperative, and postoperative medical d­
ata obtained from children with intracranial tumors, espe­
cially astrocytomas. It has shown good correlation with 
other neuropsychological scores and is a good tool for in­
vestigating the psychological impact of brain tumors and 
their treatment.
Conclusions
Any study, from a simple case series to a randomized 
multicenter study, should have well-defined outcomes that 
are clearly stated before the data are collected. Until re­
cently, the outcomes of interest to most surgeons were 
those that were directly affected by the disease or the in­
tervention, such as survival, recurrence, complications, 
and extent of resection. In an effort to understand the im­
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pact of the disease and treatment on children better, there 
has been an effort to incorporate more elaborate outcome 
measures, especially ones derived from the patients or 
their families.
The process of designing and evaluating outcome scales 
is complex and has multiple stages. Each outcome measure 
undergoes a process of reevaluation until it becomes ac­
cepted as a useful measure. Despite the numerous method­
ological obstacles presented when designing and imple­
menting outcome measures in the pediatric population, 
numerous generic and specific outcome measures can be 
applied in the field of pediatric neurosurgery.
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